NSEGeneral Updates1d ago · 14 Oct 2026, 06:06 pm

General Updates

Godavari Biorefineries Limited · GODAVARIB

✦ AI Summary▲ PositiveESG

Godavari Biorefineries Limited has informed the Exchange about General Updates, a United States-based patent application, entitled '5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER', has been granted.

Analysis Scores

Earnings Impact2/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Godavari Biorefineries Limited has informed the Exchange about General Updates a United States-based patent application, entitled "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER", has been granted

Attachments (1)

📄

GODAVARIBIO_14102026180611_Intimation_to_SE.pdf

pdf

Download →
View document text
Dated: October 14, 2026 The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Tower, Bandra Kurla Complex, Bandra (E), Dalal Street Mumbai – 400 051 Mumbai-400001 Script Symbol: GODAVARIB Script Code:544279 Dear Sir / Madam, Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is to inform you that our United States-based patent application, entitled "5-HYDROXY-1,4- NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER” has been granted. This patent protects a novel class of compounds that e(cid:431)ectively inhibit cancer and cancer stem cells, showing significant potential against various cancer types, including breast and prostate. The grant certificate is attached herewith for reference. This is for your information and records. Thanking you, Yours faithfully For Godavari Biorefineries Limited Manoj Jain Company Secretary and Compliance O(cid:431)icer Membership No. F-7998